Journal
FREE RADICAL BIOLOGY AND MEDICINE
Volume 166, Issue -, Pages 238-254Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2021.02.047
Keywords
AMPK; ROS; Nox; Ischemia; Reperfusion; Ischemia; reperfusion injury; Cardiac hypertrophy; Heart failure; HFrEF; HFpEF
Funding
- Fonds National de la Recherche Scientifique (FNRS), Belgium [T.0011.19]
- Action de Recherche Concertee de la Communaute Wallonie-Bruxelles, Belgium [ARC 18/23-094, CS/14/3/31002]
- DukeNUS Signature Research Programme - Ministry of Health
- Singapore Ministry of Health's National Medical Research Council [NMRC/CGAug16C006, NMRC/CSA-SI/0011/2017]
- European Union (ERDF)
- Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call RESEARCH CREATE -INNOVATE [5048539]
- COST (European Cooperation in Science and Technology) [CA16225]
Ask authors/readers for more resources
Heart failure is a major cause of death and disability globally, with left ventricular remodeling, fibrosis, and ischemia/reperfusion injury contributing to cardiac dysfunction. AMPK acts as a universal energy sensor in response to low ATP levels, playing a crucial role in the heart. Excessive reactive oxygen species can activate AMPK, providing an additional role as a redox sensor for preventing heart failure progression.
Heart failure is one of the leading causes of death and disability worldwide. Left ventricle remodeling, fibrosis, and ischemia/reperfusion injury all contribute to the deterioration of cardiac function and predispose to the onset of heart failure. Adenosine monophosphate-activated protein kinase (AMPK) is the universally recognized energy sensor which responds to low ATP levels and restores cellular metabolism. AMPK activation controls numerous cellular processes and, in the heart, it plays a pivotal role in preventing onset and progression of disease. Excessive reactive oxygen species (ROS) generation, known as oxidative stress, can activate AMPK, conferring an additional role of AMPK as a redox-sensor. In this review, we discuss recent insights into the crosstalk between ROS and AMPK. We describe the molecular mechanisms by which ROS activate AMPK and how AMPK signaling can further prevent heart failure progression. Ultimately, we review the potential therapeutic approaches to target AMPK for the treatment of cardiovascular disease and prevention of heart failure.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available